• PDF / 169,588 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 94 Downloads / 185 Views

DOWNLOAD

REPORT

---

1 S

Uterine rupture: 9 case reports In a French observational retrospective study involving 339 women (study conducted from 01 January 2013 to 26 October 2016), nine women aged 25.42–38.7 years were described, who exhibited uterine rupture following administration of oxytocin or dinoprostone for labour augmentation or induction of labour during delivery [dosages, durations of treatments to reactions onsets and outcomes not stated]. The pregnant women, who were hospitalised in France, received IV oxytocin for labour augmentation during delivery (5 patients), vaginal dinoprostone [prostaglandin E2] and IV oxytocin for labour induction during delivery (2 patients) or vaginal dinoprostone for labour induction during delivery (2 patients). Additionally, one of the nine women received levothyroxine sodium during pregnancy. However, the women exhibited uterine rupture, which was attributed to dinoprostone or oxytocin. At 38.1–40.6 weeks of gestation, the women delivered male babies or female babies via caesarean section. The weights of the babies were 2840–3730 [units not stated]. The length of the women’s hospital stay was 4–7 days. Vecchioli E, et al. Maternal and neonatal outcomes associated with induction of labor after one previous cesarean delivery: A French retrospective study. PLOS One 15: No. 803515529 8, 07 Aug 2020. Available from: URL: http://doi.org/10.1371/journal.pone.0237132

0114-9954/20/1832-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 28 Nov 2020 No. 1832